NIAID offers a comprehensive suite of resources and services that address gaps along the product development pathway. These services assist in the development of the next generation of vaccines, diagnostics, and therapeutics for a broad array of bacterial, viral, fungal, and parasitic pathogens. Eligible investigators worldwide can get access to expertise, research materials, and state-of-the-art technologies.
Benefits of Using NIAID Services
- Minimal or no charge
- Encouragement of scientists to develop products that can be used to reduce the burden of infectious diseases
- Offer expertise in product development
- Help move promising discoveries along the product development pathway
- Fill gaps in product development programs to reduce risk for developers
- Ensure confidentiality and maintain intellectual property of the product developer
Product Development Pathway
NIAID Preclinical Services
Vaccines & Other Biologics
NIAID offers services that can help get vaccines and other biologics to production such as:
- Evaluation and testing
- Manufacturing
Diagnostics
NIAID can help you get your diagnostics product to development through:
- Product development processes
- Assay development
- Sample preparation
Therapeutics
NIAID services help facilitate getting therapeutics to production such as:
- In vitro assessment of antimicrobial activity
- Chemistry, ADME, in vivo PK, and toxicology
- GMP drug substance and product manufacturing
- Includes biopharmaceuticals
Preclinical Models of Infectious Diseases
NIAID offers the following models of infectious disease to help you reach the next phase of evaluation:
- Development and refinement of animal models
- In vivo efficacy screening and testing of therapeutics and vaccines
- Supplying model-derived reagents
Who Is Eligible?
Support services are available to the following applicants:
- Product developers from academia, non-profit organizations, industry, and government
- Domestic or foreign institutions
- Researchers with or without NIH funding
Our simplified request process is available year-round. Support is determined based on priority, significance, innovation, preliminary data, value, and product development plan.
Contact Us To Discuss Preclinical Service Options
Download a PDF of the NIAID Preclinical Services to Address Key Product Development Gaps infographic.